AbdAlhafiz AI,Elleboudy NS,Aboshanab KM,Aboulwafa MM,Hassouna NA .2023 .Phenotypic and genotypic characterization of linezolid resistance and the effect of antibiotic combinations on methicillinresistant Staphylococcus aureus clinical isolates. , 22(1) : 23.
Ali GH,Seiffein NL .2021 .Association of some virulence genes in methicillin resistant and methicillin sensitive Staphylococcus aureus infections isolated in community with special emphasis on pvl/mecA genes profiles in Alexandria, Egypt. Gene Rep, 25 : 101334.
Angioni D,Hites M,Jacobs F and De Breucker S M .2020 .Predictive factors of in-hospital mortality in older adults with community-acquired bloodstream infection. J. Frailty Aging, 9(4) : 232-7.
Cai X,Lin Y,Wu B,Luo Y,Li K Y .2025 .Sputum microbiota profiles of patients with rifampicin-resistant tuberculosis during the intensive-phase treatment. BMC Microbiol, 25 : 373.
Candel FJ,Salavert M,Estella A,Ferrer M,Ferrer R,Gamazo JJ,García-Vidal C,Del Castillo JG,GonzálezRamallo VJ,Miron-Rubio M .2023 .Ten issues to update in nosocomial or hospital-acquired pneumonia: An expert review. J. Clin. Med, 12(20) : 6526.
Chung H,Kim E,Yang E,Lee YW,Park JH,Bae S,Jung J,Kim MJ,Chong YP,Kim SH,Lee SO .2021 .Creactive protein predicts persistent bacteremia caused by community-acquired methicillin-resistant Staphylococcus aureus strain. Eur. J. Clin. Microbiol, 40(12) : 2497-504.
Cilloniz C,Dominedo C,Gabarrus A,Garcia-Vidal C,Becerril J,Tovar D,Moreno E,Pericas JM,Vargas CR,Torres A .2021 .Methicillin-susceptible Staphylococcus aureus in community-acquired pneumonia: risk factors and outcomes. J. Infect., 82(1) : 76-83.
Dennis LS,Daniel H,Harry L,John LH,Donald HB,Barry H,Linezolid MRSA Study Group H .2002 .Linezolid versus vancomycin for the treatment of methicillinresistant Staphylococcus aureus infections. Clin. Infect. Dis., 34(11) : 1481-90.
Duraiswamy S,Agarwalla S,Lok KS,Tse YY,Wu R,Wang Z R .2023 .A multiplex Taqman PCR assay for MRSA detection from whole blood. PLoS One, 18(11) : e0294782.
Eslami M,Safaripour A,Banihashemian SZ,Nikjoo Niaragh S,Hemmati MA,Shojaeian A,Fakhariyan S,Rabbani A,Oksenych V .2025 .Innovative antibiotic therapies for carbapenem-resistant gramnegative bacterial infections: Clinical efficacy, safety and comparative studies. Microorganisms, 13(2) : 295.
Gatti M,Viaggi B,Rossolini GM,Pea F,Viale P F .2023 .Targeted therapy of severe infections caused by Staphylococcus aureus in critically ill adult patients: A multidisciplinary proposal of therapeutic algorithms based on real-world evidence. , 11(2) : 394.
Guo LY,Yan SZ,Tao X,Yang Q,Li Q,Wang TS,Yu SQ,Chen SL .2020 .Evaluation of hypocrellin Aloaded lipase sensitive polymer micelles for intervening methicillin-resistant Staphylococcus aureus antibioticresistant bacterial infection. Mater Sci. Eng, 106 : 110230.
Hayakawa K,Yamaguchi T,Ono D,Suzuki H,Kamiyama J,Taguchi S,Kiyota K S .2020 .Two cases of intrafamilial transmission of community-acquired methicillin-resistant Staphylococcus aureus producing both PVL and TSST-1 causing fatal necrotizing pneumonia and sepsis. Infect. Drug Resist, 13 : 2921-7.
He H and Wunderink RG .2020 .Staphylococcus aureus pneumonia in the community. In Seminars in Respiratory and Critical Care Medicine, 41(04) : 470-479.
Hyun H,Song JY,Yoon JG,Seong H,Noh JY,Cheong HJ,Kim WJ .2022 .Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance and clinical outcomes. PLoS One, 17(6) : e0270261.
Ibrahim RA,Berhe N,Mekuria Z,Seyoum ET,BaladaLlasat JM,Abebe T,Mariam SH,Tsige E,Wang SH .2023 .Antimicrobial resistance and virulence gene profile of clinical Staphylococcus aureus: A multi-center study from Ethiopia. Infect Drug Resist. , 16 : 4835-44.
Ismael R,Alhameedawi AK,Abbas RS,Alsallameh S,Amer H,Firat M,Karkhane M M .2023 .Virulence genes and methicillin-resistant gene detection and antimicrobial resistance profiles isolated from different infection sites. Egypt Pharm. J., 22(2) : 265-71.
Jones BE,Ying J,Stevens V,Haroldsen C,He T,Nevers M,Christensen MA,Nelson RE,Stoddard GJ,Sauer BC,Yarbrough PM .2020 .Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia. JAMA Intern. Med, 180(4) : 552-60.
Kawasuji H,Nagaoka K,Tsuji Y,Kimoto K,Takegoshi Y,Kaneda M,Murai Y,Karaushi H,Mitsutake K,Yamamoto Y .2023 .Effectiveness and safety of linezolid versus vancomycin, teicoplanin, or daptomycin against methicillin-resistant Staphylococcus aureus bacteremia: A systematic review and meta-analysis. Antibiotics., 12(4) : 697.
Kohno S,Yamaguchi K,Aikawa N,Sumiyama Y,Odagiri S,Aoki N,Niki Y,Watanabe S,Furue M,Ito T,Croos-Dabrera R .2007 .Linezolid versus vancomycin for the treatment of infections caused by methicillinresistant Staphylococcus aureus in Japan. , 60(6) : 1361-9.
Loaiza WM,Ruiz AK,Patiño CC,Vivas MC .2023 .Bacterial resistance in hospital-acquired infections acquired in the intensive care unit: A systematic review. Acta. Med, 66(1) : 1-10.
Ma A,Dong M,Cheng J,Liao X,Dong W,Liu C,Hu C,Yang J,Kang Y .2023 .Clinical efficacy and safety of linezolid in intensive care unit patients. J. Intensive Med, 3(1) : 65-72.
Moazen J,Zaniani FR,Asghar BH .2022 .Characterization of virulence genes and antibiotic resistance of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA) isolates in intensive care unit (ICU) and non-ICU wards. Trends Med. Sci., 2(2) : e129037.
Papan C,Schroder M,Hoffmann M,Knoll H,Last K,Albrecht F,Geisel J,Fink T,Gartner BC,Mellmann A,Volk T .2021 .Combined antibiotic stewardship and infection control measures to contain the spread of linezolid-resistant Staphylococcus epidermidis in an intensive care unit. Antimicrob. Resist Infect. Control., 10(1) : 99.
Peng Z,Zhou JA,Tian L JA .2020 .Pathogenic characteristics of sputum and bronchoalveolar lavage fluid samples from patients with lower respiratory tract infection in a large teaching hospital in China: A retrospective study. BMC Pulm. Med, 20(1) : 233.
Pichon M,Micaelo M,Rasoanandrasana S,Menn AM .2021 .Molecular characterization of Staphylococcus aureus isolates derived from severe pneumonia: A retrospective monocentre study. Infect Dis, 53(11) : 811-9.
Pickens CI,Wunderink RG .2022 .Methicillinresistant Staphylococcus aureus hospital-acquired pneumonia/ventilator-associated pneumonia. In Seminars Respir Crit. Care Med, 43(02) : 304-309.
Profir I,Popescu CM,Nechita A .2025 .Fatal influenza B-MRSA coinfection in a healthy adolescent: Necrotizing pneumonia, Cytokine storm and multiorgan failure. Children., 12(6) : 766.
Rao GG,Konicki R,Cattaneo D,Alffenaar JW,Marriott DJ,Neely M,IATDMCT Antimicrobial Scientific Committee M .2020 .Therapeutic drug monitoring can improve linezolid dosing regimens in current clinical practice: A review of linezolid pharmacokinetics and pharmacodynamics. , 42(1) : 83-92.
Rongrungruang Y,Plongla R,Pleumkanitkul S,Hantrakun V,Khawcharoenporn T .2025 .Etiology of hospitalacquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) in tertiary-care hospitals in Thailand: A multicenter, retrospective cohort study. Infect. Drug Resist, 18 : 351-61.
Russo A,Salini S,Gava G,Merra G,Piccioni A,De Matteis G,Tullo G,Novelli A,Petrucci M,Gasbarrini A,Landi F A .2023 .Reduced prognostic role of serum PCT measurement in very frail older adults admitted to the emergency department. , 12(6) : 1036.
Schoevaerdts D,Sibille FX,Gavazzi G .2021 .Infections in the older population: What do we know?. Aging Clin. Exp. Res., 33(3) : 689-701.
Shi Y,Wu HL,Wu YH,Li S,Zhang LY,Xu SS,Huang HY,Zhang CH,Yu XB,Cai K,Zhang J .2023 .Safety and clinical efficacy of linezolid in children: A systematic review and meta-analysis. World J. Pediatr., 19(2) : 129-38.
Silva V,Almeida L,Gaio V,Cerca N,Manageiro V,Caniça M,Capelo JL,Igrejas G,Poeta P .2021 .Biofilm formation of multidrug-resistant MRSA strains isolated from different types of human infections. Pathogens., 10(8) : 970.
Solmaz I,Kalın BS .2021 .Assessment of antibiotic resistance of infectious agents in patients with pneumonia in tertiary critical care unit and effect on clinical outcomes. Int. J. Clin. Pract, 75(4) : e13872.
Touaitia R,Mairi A,Ibrahim NA,Basher NS,Idres T,Touati A .2025 .Staphylococcus aureus: A review of the pathogenesis and virulence mechanisms. , 14(5) : 470.
Vo-Pham-Minh T,Tran-Cong D,Phan-Viet H,Dinh-Chi T,Nguyen-Thi-Hong T,Cao-Thi-My T,Nguyen-ThiDieu H,Vo-Thai D,Nguyen-Thien V,Duong-Quy S .2024 .Staphylococcus aureus pneumonia in Can Tho, Vietnam: Clinical characteristics, antimicrobial resistance profile and risk factors of mortality. , 10(2) : 193-205.
Watkins RR,Lemonovich TL,File TM .2012 .An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): Place in therapy. Core Evid, 7 : 131-43.
Yayan J,Ghebremedhin B,Rasche K B .2015 .No outbreak of vancomycin and linezolid resistance in Staphylococcal pneumonia over a 10-year period. PLoS One, 10(9) : e0138895.
Zou J,Xiao Y,Zhang L,Zuo Z,Wang X,Liao X,Cui N,Jin J,Qian Z,Wu A,Li C .2025 .Enhanced insights into immunity traits of elderly patients in the intensive care unit with infections: Evidence from a multicenter, prospective observational study. Crit. Care., 29(1) : 386.